Summary
In this intraindividual, placebo-controlled, double blind study the dynamic effects of single doses of ouabain 0.5 mg i.v. and 12 mg sublingual were compared with those of the vasodilator sublingual nitroglycerin 0.8 mg. In 12 (sublingual) and 6 (i.v.) healthy volunteers, respectively, cardiac performance was assessed for 60 min after administration, using systolic time intervals (QS2c, PEPc, PEP/LVET), electrical impedance cardiography ((dZ/dt)/RZ index) and echocardiography (EDD, ESD, FS). After i.v. ouabain the typical positive inotropic glycoside effects appeared (shortening of QS2c, PEPc, and PEP/LVET, increase of (dZ/dt)/RZ and FS, decrease of EDD and ESD). With nitroglycerin preload reduction diminished cardiac performance, as shown by a rise in PEPc and PEP/LVET and depression of (dZ/dt)/RZ. In addition, EDD (not significant) and ESD were somewhat reduced, FS was enhanced, and QS2c tended to shorten. Following sublingual ouabain, QS2c was unchanged, there was an increase in PEPc and PEP/LVET, a decrease in (dZ/dt)/RZ and FS, EDD was unchanged, and ESD rose. By this route the absolute magnitude of the effects was about 1/3 that of the i.v. drug action. The spectrum of effects of sublingual ouabain indicates a reduction in cardiac performance without any detectable inotropic action. The effects seem to be induced by load changes, with an indication of an increase in afterload although an additional preload reduction cannot be excluded. This dose of the drug given by the sublingual route appears, therefore, to alter cardiac function via an effect on the peripheral circulation, although the final mechanism has not yet been elucidated. It is not known whether these biological effects in healthy subjects may have any clinical significance in patients with cardiac disorders.
Similar content being viewed by others
References
Balasubramanian V, Arun Behl, Das GS, Wadhwa AK, Mathew OP, Hoon RS (1978) Effect of digoxin and diuretics on high altitude left ventricular dysfunction. Circulation 57: 1180–1185
Belz GG, Erbel R, Schumann K, Gilfrich HJ (1978) Dose-response relationships and plasma concentrations of digitalis glycosides in man. Eur J Clin Pharmacol 13: 103–111
Belz GG, Aust PE, Schneider B (1981) Time course of effects of single intravenous doses of digitoxin and digoxin in normal volunteers. J Cardiovasc Pharmacol 3: 1116–1125
Belz GG, Aust PE, Belz G, Appel E, Palm D (1982) Sympathomimetic effects of amezinium on the cardiovascular system and plasma catecholamines in man. Eur J Clin Pharmacol 23: 15–20
Brecht T, Bodem G, Schäfer E (1978) Digitaliswirkung auf die Extremitätendurchblutung des Menschen. Klin Wochenschr 56: 515–519
Buch J, Egeblad H, Hansen PB, Kjaergard H, Waldorff S, Steiness E (1980) Correlation between changes of systolic time intervals and left ventricular end-diastolic diameter after preload reduction. Non-invasive monitoring of pharmacological intervention. Br Heart J 44: 668–671
De Mots H, Rahimtoola SH, Kremkau EL, Bennett W, Mahler D (1976) Effects of ouabain on myocardial oxygen supply and demand in patients with chronic coronary artery disease. J Clin Invest 58: 312–319
De Mots H, Rahimtoola SH, McAnulty JH, Porter GA (1978) Effects of ouabain on coronary and systemic vascular resistance and myocardial oxygen consumption in patients without heart failure. Am J Cardiol 41: 88–93
Dohrmann RE, Janisch HD, Kessel M (1977) Klinisch-poliklinische Studie über die Wirksamkeit von g-Strophanthin bei Angina pectoris and Myocardinfarkt. Card Bull Acta Cardiol 14/15: 183–187
Erdle HP, Schultz KD, Wetzel E, Gross F (1979) Resorption und Ausscheidung von g-Strophanthin nach intravenöser und perlingualer Gabe. Dtsch Med Wochenschr 104: 976–979
Feigenbaum H (1981) Echocardiography. 3rd edition, Lea and Febiger, Philadelphia, USA
Forester W, Lewis RP, Weissler AM, Wilke TA (1974) The onset and magnitude of the contractile response to commonly used digitalis glycosides in normal subjects. Circulation 49: 517–521
Greeff K (1974) Bestimmungen des Blutspiegels von Digoxin, Digitoxin und g-Strophanthin mit Hilfe radioimmunologischer Methoden. Herz/Kreislauf 6: 145–149
Greeff K, Köhler E, Strobach H, Verspohl E (1974) Zur Pharmakokinetik des g-Strophanthin. Verh Dtsch Ges Kreislaufforsch 40 Steinkopff, Darmstadt p. 301–305
Grizzle JE, Allen DM (1969) Analyses of growth and dose response curves. Biometrics 25: 357–383
Harris WS, Schoenfeld CD, Weissler AM (1967) Effects of adrenergic receptor activation and blockade on the systolic pre-ejection period, heart rate, and arterial pressure in man. J Clin Invest 46: 1704–1714
Hirshleifer J, Crawford M, O'Rourke RA, Karliner JS (1975) Influence of acute alterations in heart rate and systemic arterial pressure on echocardiographic measures of left ventricular performance in normal human subjects. Circulation 52: 835–841
Kubicek F, Reisner T (1973) Hypoxietoleranz bei koronarer Herzkrankheit unter Einwirkung von Digoxin, Beta-Methyl-Digoxin und g-Strophanthin. Ther Gegenw 112: 747–769
Lehmann HU, Witt E, Hochrein E (1979) Wirkungen von Nitroglyzerin auf digitalisinduzierte ST-Streckensenkungen bei koronarkranken Patienten. Dtsch Med Wochenschr 104: 501–506
Lewis RP, Rittgers SE, Forester WF, Boudoulas H (1977) A critical review of the systolic time intervals. Circulation 56: 146–158
Loeb HS, Steitmatter N, Braunstein D, Jacobs WR, Croke RP, Gunnar RM (1979) Lack of ouabain effect on pacing-induced myocardial ischemia in patients with coronary artery disease. Am J Cardiol 43: 995–1000
Mason DT, Braunwald E (1964) Studies on digitalis. X. Effects of ouabain on forearm vascular resistance and venous tonus in normal subjects and in patients with heart failure. J Clin Invest 43: 532–537
Parker JO, West RO, Ledwich JR, di Gorgi S (1969) The effect of acute digitalization on the hemodynamic response to exercise in coronary artery disease. Circulation 40: 453–462
Paz de la LR, Kerigan AT, Koch GG, Kolman WA, Spodick DH (1979) Erythrityl tetranitrate: sustained effects on systolic time intervals. Changes consistent with sustained preload reduction. Am J Med Sci 277: 173–178
Rodman T, Gorczyca CA, Pastor BH (1961) The effects of digitalis on the cardiac output of the normal heart at rest and during exercise. Ann Intern Med 55: 620–631
Ross J, Waldhausen JA, Braunwald E (1960) Studies on digitalis. I. Direct effects on peripheral vascular resistance. J Clin Invest 39: 930–936
Ross J, Braunwald E, Waldhausen JA (1960) Studies on digitalis. II. Extracardiac effects on venous return and on the capacity of the peripheral vascular bed. J Clin Invest 39: 937–942
Weissler AM, Snyder JR, Schoenfeld CD, Cohen S (1966) Assay of digitalis glycosides in man. Am J Cardiol 17: 768–780
Weissler AM, Harris WS, Schoenfeld CD (1968) Systolic time intervals in heart failure in man. Circulation 37: 149–159
Williams MH, Zohmann LR, Ratner AC (1958) Hemodynamic effects of cardiac glycosides on normal human subjects during rest and exercise. J Appl Physiol 13: 417–421
Author information
Authors and Affiliations
Additional information
The results form part of the medical inauguration thesis of U. Sauer
Rights and permissions
About this article
Cite this article
Belz, G.G., Matthews, J., Sauer, U. et al. Pharmacodynamic effects of ouabain following single sublingual and intravenous doses in normal subjects. Eur J Clin Pharmacol 26, 287–292 (1984). https://doi.org/10.1007/BF00548756
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00548756